Categories: News

Association of Bioscience Financial Officers Announces Preliminary Program for 2025 National Conference in San Diego May 27-30

The Theme for the 2025 ABFO National Conference is “More Than Just Numbers,” and It Will Explore Topics Such as The Power of Artificial Intelligence, Investor Relations Excellence, Fundraising and Cash Flow Management, M&A and IPO Success Stories, Current Global Economic Trends, Leadership and Capital Allocation Strategies

The 3-Day Event Offers Up to 18 hours of CPE

SAN DIEGO, Jan. 8, 2025 /PRNewswire/ — The Association of Bioscience Financial Officers (ABFO) today announced the preliminary program for its 2025 National Conference, which is set to take place May 27-30 at the Omni Hotel in San Diego. As the premiere and largest gathering for CFOs and those who aspire to be CFOs in the bioscience industry, the annual conference will include sessions with renowned speakers, continuous networking opportunities with financial and accounting thought leaders, high-caliber panels offering valuable insights from successful industry experts, social events, and focused breakout sessions. The 2025 ABFO National Conference is the only annual event designed for financial leaders in the life sciences industry and offers unique opportunities to enhance careers and company operations in this field.

Through the theme of “More Than Just Numbers,” the annual conference will feature:

  • Moderated Q&A Session with Drew Brees, former NFL Quarterback for the New Orleans Saints and San Diego Chargers, 2009 Super Bowl MVP and Cofounder of the Brees Dream Foundation
  • Keynote Presentation by Joe Quinlan, Managing Director and Chief Market Strategist, Merrill Wealth Management, Bank of America, focused on current global economic trends
  • Keynote Presentation by John Foley, Legendary Solo Pilot of the Blue Angels Flight Team and Best-Selling Author, centered on The Glad To Be Here® Mindset
  • Fireside Chat with Joe Kudla, Founder and CEO of Vuori, one of the fastest growing brands in the world

Click here to register for the conference at a discounted rate. Price is available through January 16:

https://abfoconference.org/2025-abfo-conference-registration/

Click here to see the preliminary conference agenda:

https://www.abfointernational.org/2025/2025Agenda.html

Click here for general conference information:

https://abfoconference.org/2025conference/

The ABFO National Conference is sponsored by Aon, Bank of America Merrill Lynch, EY, Oxford Finance, Capital Advisors Group, Condor, Coupa, DFIN, Marsh, Cooley, Goodwin and supported by Russo Partners. 

Media Contacts
Ignacio Guerrero-Ros, Ph.D., or Elio Ambrosio
Russo Partners, LLC
Ignacio.guerrero-ros@russopartnersllc.com
Elio.ambrosio@russopartnersllc.com
(646) 249-6817

 

View original content:https://www.prnewswire.com/news-releases/association-of-bioscience-financial-officers-announces-preliminary-program-for-2025-national-conference-in-san-diego-may-27-30-302345255.html

SOURCE The Association of Bioscience Financial Officers

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

40 minutes ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago